Simple aspiration and drainage and intrapleural minocycline pleurodesis versus simple aspiration and drainage for the initial treatment of primary spontaneous pneumothorax: an open-label, parallel-group, prospective, randomised, controlled trial. Comment This open-label, parallel-group, prospective, randomised, controlled trial from Taiwan included 214 adults presenting with a first episode of primary spontaneous pneumothorax (PSP) with a rim of air >2 cm on radiographs and complete lung expansion without air leakage after pigtail catheter drainage. Patients were randomly assigned (1:1) to receive 300 mg of minocycline pleurodesis or no treatment (control group). The rate of recurrence of pneumothoraces at 1 year (primary endpoint) was 29.2% in the minocycline group (vs 49.1% in the control group, p=0·003).
This study highlighted that the recurrence rate of PSP >2cm is high. Simple aspiration and drainage followed by minocycline pleurodesis is safe and can reduce recurrence.
Simple aspiration and drainage and intrapleural minocycline pleurodesis versus simple aspiration and drainage for the initial treatment of primary spontaneous pneumothorax: an open-label, parallel-group, prospective, randomised, controlled trial. were noted with breath-holding compared with controls. Lesion size (longitudinal diameter) and depth of lesion (distance from pleura) were also independent risk factors for pneumothorax.
Authors
Breath-hold after forced expiration before removal of the biopsy needle decreased the rate of pneumothorax in CT-guided transthoracic lung biopsy.
Influence of previous use of inhaled corticoids on the development of pleural effusion in community-acquired pneumonia Comment: Although inhaled corticosteroid (ICS) in COPD have been associated with increased risk of community acquired pneumonia (CAP) they have been shown to be associated with decreased pneumonia related mortality and fewer pneumonia complications. The aim of this study was to assess if previous ICS use influenced the incidence of parapneumonic effusions. This single centre prospective observational study included 3612 consecutive patients with CAP of which 633 (17%) were on ICS therapy (COPD 54%, asthma13% and other disorders) before the diagnosis of CAP.
The incidence of parapneumonic effusion was lower in patients with ICS use compared to non-ICS patients (5% vs 12%; p<0.001). After matching for propensity scores, the use of ICS was still associated with a lower risk of parapneumonic effusion (OR 0.40; 95%CI 0.23-0.69; p<0.001). Interestingly pleural fluid analysis suggested less pleural inflammation in patients using ICS with lower levels of protein and lactate and significantly higher levels of pH and glucose. This is potentially due to a local anti-inflammatory effect in the pleura. A clinical score (RAPID) to identify those at risk of poor outcome at presentation with pleural infection VOLUME 6, ISSUE 4
A high risk RAPID score (>4/7) was associated with a significant increase in mortality (OR 14.1, 95%CI3.5-56.8; p<0.001) and an increased duration of hospitalisation. The RAPID score may allow for risk-stratification of patients with pleural infection at presentation and may be useful in particular circumstances eg clinical trial designs. As most patients are treated practically the same in pleural infection, the clinical utility of this tool in guiding initial management decisions remains to be seen.
The variables in the RAPID scoring system are indicative of the underlying general condition of the patient rather than the severity of pleural infection and highlight once again that death from pleural infection is related to the underlying host factor (eg age, multi-organ -including renalfailure and poor nutrition states). Comment: Infection is often the major concern that deters the use of indwelling pleural catheters (IPC) in the management of recurrent (especially malignant) pleural effusions. This largest (n=1021 IPC patients) review from 11 centres of patients showed that IPC related infection was not common (4.9%). The majority (94%) of cases were successfully managed with antibiotic therapy alone without requiring IPC removal. The overall risk of death from pleural infection was only 0.29%. In nearly half the cases (48%) Staphylococcus aureus was the causative organism whilst infections with gram-negative organisms were more often associated with need for long term antibiotic therapy. Pleurodesis developed in more than half (62%) of patients with IPC related pleural infection. 
READ the latest issues of Respirology and Respirology Case Reports
Follow us on Twitter
